More Information on 'Array Bridge Inc'

Array Bridge is a company that provides products and services to the pharmaceutical and biotechnology industry, primarily in the fields of biologics development and functional proteomics. The company offers a range of products, including enzyme assays, antibody arrays, and ELISA kits, which are used for biosimilar comparability analysis, biomarker discovery, and drug target identification. Array Bridge's services include protein conformational analysis, host cell protein and binding-based bioassay method qualification and validation, and enzyme assay services for over 850 enzymes. The company's technology, such as Protein Conformational Arrays and PEP (Protein Elution Plate) technology, enables the systematic measurement of biologics conformational comparability and the development of functional proteome landscapes. Overall, Array Bridge's products and services aim to support the development of biologics, including biosimilars, and provide valuable insights into protein functions and biomarker discovery.

About Array Bridge Inc
Array Bridge Inc. was founded by scientists with extensive experience in drug discovery and biologics development. Array Bridge provides products and services that address two important areas in the development of biologics: biosimilar drug comparability analysis and impurity analysis. Array Bridge has developed "antibody arrays" to measure biosimilar drug comparability at the molecular level, providing a sensitive, systematic and robust measurement of biosimilar conformational comparability. This antibody array-based technology can be used at all stages of biosimilar development, from cell line selection and process development to clinical testing and product release. For impurity analysis, Array Bridge provides ELISA kits and reagents for Host Cell Protein quantitation and Western Blot analysis. All the products are manufactured under cGMP to ensure quality and consistency.

Looking for Channel Partners in: